Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C. Orozco Gonzalez"'
Autor:
O. J. Felipe Díaz, Jesús-Giovanny Ballesteros, C. L. Giraldo Herrera, J. Barbosa Camacho, N. Duque Zapata, C. Orozco Gonzalez, J. H. Donado Gómez, W. G. Rojas Zuleta
Publikováno v:
Annals of the Rheumatic Diseases. 80:1139.2-1139
Background:Biological therapy revolutionized the treatment and prognosis of inflammatory arthropathies; however, its high cost has an economic impact on health system and limits its access. Biosimilars are products with similar molecular structure, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9319a1970ca8045532063acaa0d0db55
https://doi.org/10.1136/annrheumdis-2021-eular.2592
https://doi.org/10.1136/annrheumdis-2021-eular.2592
Autor:
O. J. Felipe Díaz, J. G. Lopéz Velandia, A. E. Pantoja Marquez, J. Barbosa Camacho, N. Duque Zapata, J. H. Donado Gómez, C. Orozco Gonzalez, W. G. Rojas Zuleta, E. P. Navarro Mendoza, R. Giraldo
Publikováno v:
Annals of the Rheumatic Diseases. 79:1457.2-1458
Background:The optimization of biological agents (bDMARD), is a strategy that has proven to be cost effective and its use can reduce the risk related to drug exposure (1–3). It is included in the EULAR management guidelines and in the consensus of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6534c3b66f0b555a8eaad3aa3213252e
https://doi.org/10.1136/annrheumdis-2020-eular.6508
https://doi.org/10.1136/annrheumdis-2020-eular.6508
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.